Maven Income
and Growth VCT PLC
Interim results for the six months ended 31
August 2024 (unaudited)
The Directors are pleased to announce the
unaudited Interim Management Report for the six months ended 31
August 2024.
Highlights
· NAV
total return at 31 August 2024 of 148.27p per share
· NAV
at 31 August 2024 of 40.71p per share
·
Increased interim dividend of 1.15p per share
· Offer for
Subscription closed, raising £6.8 million, with a new fund raising
launched in September 2024
· Two
new private companies added to the portfolio, with a further
investment completed post the period end
· Exit
achieved from GradTouch generating a total return of 1.7x
cost
· Final
exit achieved from Quorum Cyber, generating a total return of 8.2x
cost
·
Partial exit achieved from MirrorWeb, generating a total
return of 4.0x cost inclusive of a retained equity stake
·
Partial exit achieved from Novatus Global, generating a total
return of 4.7x cost with a retained equity stake
· Exit
achieved from CB Technology, generating a total return of 2.9x
cost
· Exit
achieved from QikServe, generating an initial return of 1.3x cost,
with the potential for further upside through earn out
Overview
In the six months to 31 August 2024, there has
been a strong level of M&A activity across the private company
portfolio, which has resulted in the completion of six profitable
realisations, including several high value exits to strategic US
buyers. In June, the final exit from Quorum Cyber completed, with
the sale of the residual holding, generating a total return of 8.2x
cost over the life of the investment. The partial sale of MirrorWeb
completed in August and generated a total return of 4.0x cost.
After the period end, there were further sales with the partial
exit from Novatus Global completing in early September, generating
a total return of 4.7x cost, alongside the realisations of CB
Technology and QikServe. With MirrorWeb and Novatus, the Manager
elected to take proceeds partly in cash combined with a continuing
equity stake, which allows your Company to participate in the
future growth of these businesses with scope for a further return
in the future. In recognition of the exit activity, your Board has
increased the annual dividend target from 5% to 6% per annum and is
pleased to declare an increased interim dividend of 1.15p per share
for payment in November 2024.
In the year to date, your Company has completed
six profitable private company exits to UK and US buyers, helping
to validate the Manager's investment strategy and sector focus.
Following a muted period for M&A within the technology sector
in 2023, the market has recovered strongly. Notably, there has been
a re-emergence of US private equity buyers who are attracted to UK
speciality technology companies that have a market leading product
within a high growth sector. A key part of their acquisition
rationale is to provide enhanced financial resource to help these
businesses accelerate their business plans and, when structuring an
exit, Maven will seek, where possible, to retain an equity stake to
enable your Company to share in future success.
In early June, the final exit from cyber
security specialist Quorum
Cyber completed. Your Company first invested in Quorum in
2020, backing an experienced team that had established a leading
position in a high growth market. Following a period of rapid
expansion, the investment was partially realised through a sale to
UK private equity house Livingbridge in December 2021, generating
an initial return of 6.5x cost over an 18 month holding period.
This transaction provided Quorum with additional capital to support
the next phase of its strategic development and, given the growth
prospects, the Maven VCTs retained a minority equity interest in
the business. The final exit from this investment was achieved
through a sale of the business to US private equity firm,
Charlesbank Capital Partners, taking the total proceeds to 8.2x
cost over the life of the investment.
A further notable exit was the partial sale of
digital archiving specialist MirrorWeb, which completed in August
2024. Your Company first invested in MirrorWeb in 2020, supporting
an ambitious management team who had developed a disruptive
software platform with significant growth potential and a large
addressable market. Since investment, the business delivered
consistent strong revenue growth and established a leading position
in the communications surveillance market, with a focus on the
financial services sector where the platform supports regulatory
requirements in relation to data archiving. In 2023, the business
successfully expanded into the US, which led to an unsolicited
approach from a US private equity buyer to acquire the company.
Following this approach, a competitive exit process was initiated,
with the sale to US private equity acquirer MainSail completing in
August. The exit generated a total return of 4.0x cost, comprising
of a cash consideration and a retained equity stake, which enables
your Company to maintain an economic interest in the business with
the potential for a further return in the future.
In early September 2024, the partial sale of
regtech specialist Novatus
Global completed, achieving the highest sale price to date
from the unlisted technology portfolio. Following the investment in
2022, Novatus made rapid commercial progress, capitalising on the
growth opportunities within the core market, where the advisory
services and software platform help financial institutions to
prevent and resolve regulatory and compliance issues. Over the past
two years, the business achieved a 250% increase in annual
recurring revenue (ARR), driven by the development of the
proprietary transaction reporting software platform, which is
gaining market traction and a strong industry reputation. The
business recently opened its first international office in
Australia to capture the significant opportunity in this region.
Earlier this year, Novatus received an unsolicited acquisition
approach from US private equity firm Silversmith Capital Partners
at a premium to carrying value. The exit completed in August and
generated a total return of 4.7x cost, comprised of cash and a
retained equity stake that enables your Company to participate in
future growth.
In May 2024, the exit from graduate recruitment
specialist GradTouch
completed, with a sale to a UK private equity house that generated
a total return of 1.7x cost, inclusive of a small deferred element.
Specialist electronics manufacturer CB Technology was one of the more
mature holdings in the portfolio and, following a period of strong
trading performance, an exit process was initiated in 2023. An
offer to acquire the business was subsequently received from a
trade buyer, with the exit completing in early September 2024 and
generating a total return of 2.9x cost. The exit from digital
payment software provider QikServe also completed in September,
generating an initial cash return of 1.3x cost with further
contingent proceeds, which could take the total return up to c1.8x
cost over the next two years.
Achieving profitable exits in order to maximise
Shareholder returns and distributions remains a key priority,
however, this has to be balanced against selling a business too
early and before its value has been fully optimised. In cases such
as MirrorWeb, Novatus and Quorum where a business is performing
strongly and has the potential to become a large and valuable
asset, the Manager will seek to maintain an economic interest when
structuring an exit. This approach allows your Company to generate
a healthy initial cash return from a secondary transaction or
partial sale, to help support the dividend programme, whilst
retaining an ongoing equity interest in the business, which offers
the potential for a further return in the future.
Your Company continues to make further progress
in line with its long term growth strategy, which is focused on
constructing a large and diverse portfolio of innovative companies
that have the potential to grow rapidly and ultimately become
attractive to a wide range of acquirers. During the reporting
period, there was a good level of investment with the addition of
two new private companies to the portfolio, alongside the provision
of follow-on funding to support the further development of 10
existing unlisted portfolio holdings and one small AIM transaction,
resulting in the deployment of £1.87 million. The investment
strategy continues to focus on identifying entrepreneurial
companies that operate in disruptive or high growth markets, where
there is an opportunity to achieve scale over the medium term.
Maven retains a strong preference for investing in companies that
operate in dynamic sectors such as cyber security, software, niche
manufacturing, data analytics, healthtech and training, where
growth is less sensitive to consumer or discretionary spending and
the revenue model tends to be recurring in nature, which provides
good visibility on the growth trajectory of each portfolio company.
To ensure the business plan can be delivered, Maven also spends
time assessing the calibre of management and their track record,
recognising that ambitious and cohesive teams are crucial to
success.
Enhanced
Dividend Policy
As Shareholders will be aware from
recent Interim and Annual Reports decisions on distributions take
into consideration a number of factors, including the realisation
of capital gains, the adequacy of distributable reserves, the
availability of surplus revenue and the VCT qualifying level, all
of which are kept under close and regular review. As the portfolio
continues to expand and a greater proportion of holdings are
invested in younger companies with growth potential, the timing of
distributions will be more closely linked to realisation activity,
whilst also reflecting the requirement to maintain its VCT
qualifying level.
The Board and the Manager recognise
the importance of tax free Shareholder distributions and, further
to the completion of several profitable exits, the Directors have
elected to improve the dividend policy. From the current financial
year, your Company has increased its target annual dividend from 5%
to 6% of the NAV per share at the immediately preceding year
end.
Interim
Dividend
In line with the enhanced dividend policy, the
Directors are pleased to announce that, in respect of the year
ending 28 February 2025, an increased interim dividend of 1.15p per
share will be paid on 29 November 2024 to Shareholders who are on
the register at 1 November 2024. Since the Company's launch, and
after receipt of this interim dividend, a total of 108.71p per
share will have been paid in tax free Shareholder distributions. It
should be noted that payment of a dividend reduces the NAV by the
total amount of the distribution.
Dividend
Investment Scheme (DIS)
Your Company operates a DIS, through which
Shareholders can, at any time, elect to have their dividend
payments utilised to subscribe for new Ordinary Shares issued under
the standing authority requested from Shareholders at Annual
General Meetings. Shares issued under the DIS should qualify
for VCT tax relief applicable for the tax year in which they are
allotted, subject to an individual Shareholder's particular
circumstances.
Shareholders can elect to participate in the DIS
in respect of future dividends by completing a DIS mandate form and
returning it to the Registrar (The City Partnership). In order for
the DIS to apply to the 2025 interim dividend, the mandate form
must be received before 15 November 2024, this being the relevant
dividend election date. The mandate form, terms &
conditions and full details of the scheme (including tax
considerations) are available from the webpage at:
mavencp.com/migvct.
Election to participate in the DIS can also be made through
the Registrar's online investor hub at: maven-cp.cityhub.uk.com/login.
If a Shareholder is in any doubt about the
merits of participating in the DIS, or their own tax status, they
should seek advice from a suitably qualified adviser.
Offer for
Subscription
In April, the Offer for Subscription
for the 2023/24 and 2024/25 tax years closed, raising a total of
£6.8 million. All new shares in relation to this Offer have now
been allotted, with four allotments for the 2023/24 tax year and
one allotment for the 2024/25 tax year.
This additional liquidity will facilitate the further expansion and
development of the portfolio in line with the investment strategy.
The funds raised will also allow your Company to maintain its share
buy-back policy, whilst also spreading costs over a wider asset
base with the objective of maintaining a competitive ongoing
charges ratio for the benefit of all
Shareholders.
On 27 September 2024, your Company launched a
new Offer for Subscription alongside offers by the three other
Maven managed VCTs. Your Company has a target raise of £10 million,
including the ability to utilise an over-allotment facility of up
to £5 million. The Offers remain open until 1 May 2025, unless
fully subscribed ahead of this date, and further details, including
the Prospectus, can be found at: mavencp.com/vctoffer.
Portfolio
Developments
It is encouraging to report on the progress that
has been achieved across the private equity portfolio, where most
companies have continued to meet the operational and financial
targets as set out in their business plans. Many of the earlier
stage growth companies are now achieving scale and establishing
strong positions in their respective markets, and in recognition of
the progress achieved, the valuations of certain holdings have been
uplifted.
Cyber security specialist
CYSIAM has made further commercial progress, with revenues increasing
by more than 200% since your Company first invested. The business
is building a strong reputation as a leading provider of Managed
Detection and Response (MDR) security services for protection
against, detection of, and response to cyber attacks. CYSIAM is a
recognised expert in its field and, as an accredited member of the
National Cyber Security Centre's Cyber Incident Response scheme,
can provide direct support to a range of organisations when they
become victims of cyber attacks. CYSIAM operates in a dynamic, high
growth market and the near term strategic objective remains to
further pivot the business towards a Software as a Service (SaaS)
model, which will result in an increased level of recurring
revenue.
Demand responsive transport provider
Liftango continues to
extend its global footprint. Having achieved success in Australia
and the UK, Liftango is now focused on expanding into international
markets, with the Middle East and Americas identified as key growth
territories. The business provides the technology to support
on-demand transport programmes by enabling users to plan, launch
and scale shared mobility projects that help to reduce costs by
optimising routes, whilst simultaneously addressing sustainability
goals such as decreasing carbon emissions through lower vehicle
usage, which also helps to combat localised congestion. Liftango
already operates in 21 countries and works with many Fortune 500
companies, as well as large global bus operators and government
transport agencies. With strong ESG credentials, Liftango is well
positioned to deliver sustained growth as it secures new contracts
within its target markets.
Carbon reduction software specialist
Manufacture 2030 has
delivered impressive revenue growth, with ARR doubling since your
Company first invested in 2021. The business provides a disruptive
software solution that helps multinationals achieve Scope 3 carbon
reduction targets by measuring, managing and reducing carbon
emissions across their supply chain. The business is establishing a
strong position in a high growth market, where its proposition is
aligned with various carbon reduction initiatives including the
United Nations Sustainable Development Goals. Manufacture 2030
partners with a wide range of blue chip clients, including 10 of
the major UK grocery retailers, automotive manufacturers such as
Ford, Honda and Toyota and pharma giants including AstraZeneca, GSK
and Pfizer. Manufacture 2030 has received a number of awards as a
technology pioneer within this evolving market. The near term
objective is to expand its presence in North America, which is
viewed as a key market.
Automotive ecommerce software specialist
Rockar continues to grow
market share and is now a leading provider of a disruptive white
label solution for buying and selling new and used cars online. The
business has signed commercial agreements with various high profile
automotive manufacturers such as BMW, Jaguar Land Rover, Toyota
Motor Group and Volvo UK, with development work ongoing with
several others. Rockar's new operating platform, Evolution, is gaining traction amongst
clients, with a number already using or committed to migrating
across to the new operating system. The business continues to
deliver strong revenue growth and remains focused on building
relationships with global automotive manufacturers that will enable
the company to achieve further scale.
Contract software specialist
Summize continues to make
positive commercial progress, with ARR growing by almost 200% since
the investment first completed in October 2022. The business has
developed an AI powered digital contracting software solution that
simplifies and streamlines the process for writing and renewing
contracts, helping to drive operational efficiencies for customers.
Since inception in 2018, Summize has secured numerous industry
awards for its innovation and entrepreneurialism. Having
established a strong foothold in the UK, the next phase of growth
is focused on expanding into the US, where the business has the
potential to exploit a significant market opportunity and, during
the reporting period, the Maven VCTs provided follow-on funding to
support this growth strategy
As may be expected with a large
portfolio, there are a small number of investee companies that have
not achieved commercial targets and are trading behind plan. The
performance of fintech specialist Delio has been impacted by slower than
expected sales cycles and, although corrective measures have been
taken, the business continues to trade behind plan. A protective
provision has therefore been taken against the cost of this
investment. As a result of significant underperformance, the
Manager elected not to provide further funding to Drovo and Turnkey, and the valuations of these
holdings have been written down in full.
Treasury Management
Your Company maintains a proactive approach to
treasury management, where the objective remains
to optimise the income generated from cash held prior to investment
in VCT qualifying companies, whilst meeting the requirements of the
Nature of Income condition. This is a mandatory part of the VCT
legislation which stipulates that not less than 70% of a VCT's
income must be derived from shares or securities. During 2023, the
rise in interest rates required the Board and the Manager to revise
its approach and, following a whole of market review, the
composition of the treasury management portfolio was expanded to
include holdings in leading money market funds and open-ended
investment companies (OEICs), alongside carefully selected London
Stock Exchange listed investment trusts. This approach enables your
Company to maintain compliance with the Nature of Income condition,
whilst also generating a healthy new stream of income from the
portfolio of treasury management holdings and
cash.
In line with the liquidity
requirements, there were several new investments and realisations
within this portfolio, details of which can be found in the Interim
Report.
New
Investments
During the reporting period, two new private
companies were added to the portfolio:
· Alderley Lighthouse
Labs is a provider of clinical
diagnostic testing services, specialising in the analysis of human
samples such as blood, urine and cells, with the objective of
improving healthcare outcomes. The business was initially
established as a COVID-19 testing facility, as part of the
Government supported "Test and Trace" programme. As pandemic
related testing subsided, the business evolved into a
laboratory-based facility providing blood science and molecular
diagnostics to a wide range of clients. The healthcare diagnostics
and testing market continues to experience high growth, and
Alderley is well placed to leverage its existing position, with
scope to achieve considerable scale. The funding from the Maven
VCTs provides capital that will enable the business to invest in
product development, expand its current suite of services and grow
monthly revenues.
· Zing
is a specialist services provider operating in the
cloud-communications sector. It is a leading partner of global
cloud communication platform business, Twilio, providing
consultancy and managed services. Zing was a spin out from CRM
provider ProspectSoft, a previous Maven portfolio company, which
was successfully exited in 2022. The funding from the Maven VCTs
will enable the business to benefit from the growth opportunities
in the Communications Platform as a Service (CPaaS) market. Since
becoming an independent business, Zing has made encouraging
commercial progress and strengthened its relationship with Twilio.
The next stage of development is focused on expanding into the US,
developing a new AI proposition and enhancing the management team
through new strategic hires.
In addition, a small position was
also taken in AIM quoted neuroscience technology company
Cambridge Cognition, which
is a developer and marketer of digital health products to better
understand, detect and treat conditions affecting brain health,
including Alzheimer's, Multiple Sclerosis and depression. The VCT
funding is being used to accelerate growth in this rapidly
expanding market.
The following investments were completed during
the reporting period:
Investments
|
Date
|
Sector
|
£'000
|
New unlisted
|
|
|
|
Alderley Lighthouse
Labs Limited1
|
April & May
2024
|
Pharmaceuticals,
biotechnology & healthcare
|
249
|
MirrorWeb Holdings
LLC2
|
August
2024
|
Software &
technology
|
708
|
Zing TopCo Limited
(trading as Zing)1
|
April & May
2024
|
Business
services
|
185
|
Total new unlisted
|
|
|
1,142
|
|
|
|
|
Follow-on unlisted
|
|
|
|
Automated Analytics
Limited
|
August
2024
|
Marketing &
advertising technology
|
99
|
Draper & Dash
Limited (trading as RwHealth)1
|
April & May
2024
|
Pharmaceuticals,
biotechnology & healthcare
|
51
|
Filtered Technologies
Limited
|
June 2024
|
Learning &
development/ recruitment technology
|
100
|
Hublsoft Group
Limited
|
April
2024
|
Software &
technology
|
56
|
Liftango Group
Limited
|
March
2024
|
Software &
technology
|
165
|
Plyable
Limited
|
August
2024
|
Software &
technology
|
149
|
Shortbite Limited
(trading as Fixtuur)
|
July 2024
|
Software &
technology
|
300
|
Snappy Shopper
Limited
|
April
2024
|
Software &
technology
|
11
|
Summize
Limited
|
June 2024
|
Software &
technology
|
348
|
Turnkey Group (UK)
Holdings Limited1
|
April & June
2024
|
Software &
technology
|
95
|
Total follow-on unlisted
|
|
|
1,374
|
|
|
|
|
Total unlisted
|
|
|
2,516
|
|
|
|
|
New AIM quoted
|
|
|
|
Cambridge Cognition
Holdings PLC
|
June 2024
|
Pharmaceuticals,
biotechnology & healthcare
|
63
|
Total new AIM quoted
|
|
|
63
|
|
|
|
|
Open-ended investment
companies3
|
|
|
|
Royal London Short Term
Fixed Income Fund (Class Y Income)
|
April 2024
|
Money market fund
|
1,000
|
Total open-ended investment
companies
|
|
|
1,000
|
|
|
|
|
Money market funds3
|
|
|
|
Aviva Investors
Sterling Liquidity Fund (Class 3)
|
August
2024
|
Money market
fund
|
1,000
|
BlackRock
Institutional Sterling Liquidity Fund (Core)
|
June 2024
|
Money market
fund
|
1,000
|
BlackRock
Institutional Sterling Government Liquidity Fund (Core
Dis)
|
June 2024
|
Money market
fund
|
2
|
Goldman Sachs
Sterling Government Liquid Reserves Ireland
(Institutional)
|
March
2024
|
Money market
fund
|
1,000
|
Total money market funds
|
|
|
3,002
|
|
|
|
|
Private equity investment
trusts3
|
|
|
|
Caledonia Investments
PLC
|
May 2024
|
Investment
trust
|
100
|
CT Private Equity
Trust PLC
|
May 2024
|
Investment
trust
|
141
|
Pantheon
International PLC
|
June 2024
|
Investment
trust
|
200
|
NB Private Equity
Partners Limited
|
May 2024
|
Investment
trust
|
100
|
ICG Enterprise Trust
PLC
|
May 2024
|
Investment
trust
|
54
|
Total private equity investment
trusts
|
|
|
595
|
|
|
|
|
Global equity investment
trusts3
|
|
|
|
Alliance Trust PLC
|
May 2024
|
Investment trust
|
200
|
Total global equity investment
trusts
|
|
|
200
|
|
|
|
|
Infrastructure investment
trusts3
|
|
|
|
3i Infrastructure
PLC
|
June 2024
|
Investment trust
|
100
|
BBGI Global
Infrastructure SA
|
June 2024
|
Investment trust
|
80
|
Pantheon
Infrastructure PLC
|
June 2024
|
Investment trust
|
130
|
Total infrastructure investment
trusts
|
|
|
310
|
|
|
|
|
Total investments
|
|
|
7,686
|
1
Follow-on investment completed in two tranches.
2 Retained
minority interest following the sale of MirrorWeb
Limited.
3
Investments completed as part
of the treasury management strategy.
At the period end, the portfolio comprised of
120 unlisted and quoted investments, at a total cost of £53.4
million.
Realisations
As previously outlined, this has been an
exceptional period for profitable realisations from the private
company portfolio. The table below provides details of all the
exits that have completed during the reporting period, including
GradTouch,
MirrorWeb
and Quorum Cyber
which, along with the subsequent sale of Novatus Global, provide a meaningful
increase to cash reserves.
In contrast, there have been a number of
disposals from the AIM portfolio at prices where cost has not been
recovered. Given the widely publicised challenges experienced in
the AIM market, the Manager has elected to exit certain holdings
where performance has not been in line with expectations, or where
the share price is depressed and not expected to
recover.
There remains value and upside potential within
a selected number of AIM holdings, which continue to offer the
prospect for re-rating or a strategic premium on acquisition.
However, the Manager intends to continue to rationalise the AIM
portfolio towards a residual high conviction portfolio where it has
continuing confidence in each management team and their ability to
deliver positive share price returns. New AIM investments will
continue to be considered, but only where there is a very
convincing and capital light business case, or where the Manager
believes there is an opportunity for early share price arbitrage
following investment.
Realisations
|
Year first
invested
|
Complete/
partial
exit
|
Cost of shares disposed of
£'000
|
Value at
29 February
2024
£'000
|
Sales proceeds
£'000
|
Realised
gain/ (loss)
£'000
|
Gain/(loss)
over
29 February 2024 value
£'000
|
Unlisted
|
|
|
|
|
|
|
|
GradTouch
Limited
|
2019
|
Complete
|
567
|
955
|
974
|
407
|
19
|
Life's Great Group
Limited (trading as Mojo Mortgages)1
|
2019
|
Complete
|
-
|
-
|
37
|
37
|
37
|
MirrorWeb
Limited2
|
2020
|
Complete
|
890
|
1,731
|
3,382
|
2,492
|
1,651
|
Project Falcon TopCo
Limited (trading as Quorum Cyber)
|
2021
|
Complete
|
126
|
126
|
383
|
257
|
257
|
Other
unlisted
|
|
|
1
|
-
|
1
|
-
|
1
|
Total unlisted
|
|
|
1,584
|
2,812
|
4,777
|
3,193
|
1,965
|
|
|
|
|
|
|
|
|
AIM/AQSE quoted
|
|
|
|
|
|
|
|
Destiny Pharma
PLC
|
2020
|
Complete
|
103
|
51
|
4
|
(99)
|
(47)
|
Oncimmune Holdings
PLC
|
2021
|
Complete
|
236
|
28
|
31
|
(205)
|
3
|
RUA Life Sciences
PLC
|
2020
|
Complete
|
182
|
41
|
46
|
(136)
|
5
|
Strip Tinning
PLC
|
2022
|
Complete
|
62
|
12
|
15
|
(47)
|
3
|
SulNox PLC
|
2021
|
Complete
|
33
|
39
|
36
|
3
|
(3)
|
Verici Dx
PLC
|
2022
|
Partial
|
20
|
7
|
5
|
(15)
|
(2)
|
Other AIM/AQSE
quoted
|
|
|
3
|
2
|
8
|
5
|
6
|
Total AIM/AQSE quoted
|
|
|
639
|
180
|
145
|
(494)
|
(35)
|
|
|
|
|
|
|
|
|
Money market funds3
|
|
|
|
|
|
|
|
BlackRock
Institutional Sterling Government Liquidity Fund (Core
Dis)
|
2023
|
Complete
|
1,002
|
1,002
|
1,002
|
-
|
-
|
Goldman Sachs
Sterling Government Liquid Reserves Ireland
(Institutional)
|
2023
|
Complete
|
1,000
|
1,000
|
1,000
|
-
|
-
|
Total money market funds
|
|
|
2,002
|
2,002
|
2,002
|
-
|
-
|
|
|
|
|
|
|
|
|
Open-ended investment
companies3
|
|
|
|
|
|
|
|
Royal London Short Term
Fixed Income Fund (Class Y Income)
|
2023
|
Partial
|
1,002
|
1,007
|
1,003
|
1
|
(4)
|
Total open-ended investment
companies
|
|
|
1,002
|
1,007
|
1,003
|
1
|
(4)
|
|
|
|
|
|
|
|
|
Total realisations
|
|
|
5,227
|
6,001
|
7,927
|
2,700
|
1,926
|
1
Escrow proceeds following the sale in December
2021.
2
Of the proceeds, £708,127 has been re-invested as
a retained minority interest in the continuing entity, MirrorWeb
Holdings LLC, which remains VCT qualifying for three
years.
3
Realisations completed as part of the treasury
management strategy.
During the year, one private company
was struck off the Register of Companies, resulting in a total
realised loss of £100,000 (cost £100,000). This had no effect on
the NAV of the Company as a full provision had been taken against
the value of the holding in a previous period.
Material
Developments Since the Period End
Since 31 August 2024, one new private company
has been added to the portfolio:
· Connected Data
is a provider of a data enabled debt management
software solution that is designed to improve recovery outcomes for
utility and financial services companies, which arise during
changes in tenancy and result in billions of pounds of unpaid
energy and other bills. The cloud-based platform uses propriety
technology to help manage the debt life cycle from pre-delinquency
through to late stage collection, offering a more cost effective
solution to using a single credit bureau, whilst also using
multiple data sets to ensure fairer outcomes for customers. The
business is gaining commercial traction and has quickly established
a blue chip client base. The funding from the Maven VCTs will be
used to further develop the technology platform and invest in sales
and marketing.
Principal and
Emerging Risks and Uncertainties
The principal and
emerging risks and uncertainties facing the Company were set out in
full in the Strategic Report contained within the 2024 Annual
Report, and are the risks associated with investment in small and
medium sized unlisted and AIM quoted companies which, by their
nature, carry a higher level of risk and are subject to lower
liquidity than investments in larger quoted companies. The
valuation of investee companies may be affected by economic
conditions, the credit environment and other risks including
legislation, regulation, adherence to VCT qualifying rules and the
effectiveness of the internal controls operated by the Company and
the Manager. These risks and procedures are reviewed regularly by
the Risk Committee and reported to your Board. The Board continues
to monitor the criteria for VCT qualifying status and can confirm
that these are being adhered to.
Global conflict and political instability was
added to the Risk Register as an emerging risk during a previous
period, as the Directors were not only aware of the heightened
cyber security risk but were mindful of the impact that any change
in the underlying economic conditions could have on the valuation
of investee companies. These included fluctuating interest rates,
increased fuel and energy costs, and the availability of bank
finance, all of which could be impacted during times of
geopolitical uncertainty and volatile markets. The Board and the
Manager continue to monitor the impact of geopolitical issues, and
wider market conditions, on portfolio companies.
Share
Buy-backs
In order to maintain an orderly
market in the Company's shares, the Directors have delegated
authority to the Manager to enable the Company to buy back shares
in the secondary market for cancellation or to be held in treasury,
subject always to such transactions being in the best interests of
Shareholders.
It is intended that the Company will seek to buy
back shares with a view to maintaining a share price that is at a
discount of approximately 5% to the latest published NAV per
share, subject to market conditions,
availability liquidity and the maintenance of VCT
qualifying status. During the period under review,
3,811,610 shares were bought back at a total cost of £1.42
million.
Shareholders should note that neither the
Company nor the Manager can execute a transaction in the Company's
shares and an instruction to buy or sell shares on the secondary
market must be directed through a stockbroker. If a Shareholder
wishes to discuss a transaction, they or their broker can contact
the Company's stockbroker, Shore Capital Stockbrokers on 020 7647
8132. Such transactions are, however, prohibited whilst the Company
is in a closed period, which is the time from the end of a
reporting period until the announcement of the relevant results, or
the release of an unaudited NAV. Additionally, a closed period may
be introduced if the Directors and Manager are in possession of
price sensitive information.
VCT Regulatory
Update
During the period under review, there
were no further amendments to the rules governing VCTs, and your
Company remains fully compliant with the complex conditions and
requirements as set out by HMRC.
Although the precise details of the new
Government's economic and fiscal policy are currently unknown, the
Manager has, through the VCT Association (VCTA), been actively
involved in positive cross party dialogue to promote and reinforce
the important role that VCTs play in supporting some of Britain's
brightest and most entrepreneurial smaller companies, whilst also
assisting in job creation across the regions. It is pleasing to
note that, on 3 September 2024, HM Treasury approved the
regulations required to lift the "sunset clause" and extend VCT and
EIS schemes until 2035. This provides greater certainty to
Shareholders and SMEs seeking growth capital, that VCTs will remain
a central component of the UK's funding infrastructure.
Valuation Methodology
Consistent with industry best
practice, the Board and the Manager continue to apply the
International Private Equity and Venture Capital Valuation (IPEV)
Guidelines as the central methodology for all private company
valuations. The IPEV Guidelines are the prevailing framework for
fair value assessment in the private equity and venture capital
industry. The Directors and the Manager continue to follow industry
guidelines and adhere to the IPEV Guidelines in all
private company valuations. In accordance with
normal market practice, investments quoted on AIM, or another
recognised stock exchange, are valued at their closing bid price at
the period end.
Environmental,
Social and Governance (ESG)
Whilst the Manager continues to
enhance its ESG framework, it should be noted that your Company's
investment policy does not incorporate specific ESG aims, and
portfolio companies are not required to meet any specific targets.
However, as a growth investor, Maven is well positioned to help
each portfolio company establish robust ESG practices at an early
stage of its corporate development, ensuring that they are
ingrained in the culture as the business grows. The Manager
believes that strong core ESG credentials help support responsible
growth and encourage positive social and environmental
behaviours.
Your Company has multiple investments
in companies with strong ESG credentials and which are achieving
growth in expanding markets. The Manager is committed to
maintaining a responsible approach to new and existing investments
and has developed a framework for promoting ESG credentials by
actively engaging with portfolio companies, taking into
consideration material issues at the point of investment as well as
monitoring progress annually. All potential investment
opportunities are required to complete an ESG assessment, which
covers ten key areas and provides a comprehensive pre-investment
evaluation of the business with a focus on governance, board
composition and culture, alongside environmental and social
considerations.
The Manager continues to be an active
signatory to the UN Principles for Responsible Investment (UNPRI)
and the Investing in Women Code. Alongside
these external initiatives, Maven has developed internal diversity
initiatives, including launching a Female Founder Funding programme
that aims to offer mentorship and collaboration opportunities to
female entrepreneurs across the UK.
Outlook
Whilst M&A activity in 2023 was stifled by
market uncertainty and geopolitical concerns, there has been a
strong recovery in the year to date and it is pleasing to note the
completion of several high value exits. A number of the companies
in the unlisted portfolio continue to attract regular acquisition
interest from a range of UK and international buyers and completing
further profitable exits, to help support and enhance your
Company's ongoing dividend programme, remains a key
objective.
John
Pocock
Chairman
24 October
2024
Summary of
Investment Changes
For the Six
Months Ended 31 August 2024
|
Valuation
29 February 2024
|
Net investment/ (disinvestment)
£'000
|
Appreciation/ (depreciation)
£'000
|
Valuation
31 August 2024
|
£'000
|
%
|
£'000
|
%
|
Unlisted
investments
|
|
|
|
|
|
|
Equities
|
36,073
|
59.1
|
(2,459)
|
4,155
|
37,769
|
57.8
|
Loan stock
|
8,140
|
13.3
|
198
|
(275)
|
8,063
|
12.3
|
|
44,213
|
72.4
|
(2,261)
|
3,880
|
45,832
|
70.1
|
AIM/AQSE
investments1
|
|
|
|
|
|
|
Equities
|
1,174
|
1.9
|
(82)
|
38
|
1,130
|
1.7
|
Other
investments2
|
|
|
|
|
|
|
Investment trusts
|
3,454
|
5.7
|
1,105
|
159
|
4,718
|
7.2
|
OEICs
|
2,043
|
3.4
|
(3)
|
(13)
|
2,027
|
3.1
|
MMFs
|
4,500
|
7.4
|
1,000
|
-
|
5,500
|
8.4
|
Total
investments
|
55,384
|
90.8
|
(241)
|
4,064
|
59,207
|
90.5
|
Net current assets
|
5,639
|
9.2
|
560
|
-
|
6,199
|
9.5
|
Net
assets
|
61,023
|
100.0
|
319
|
4,064
|
65,406
|
100.0
|
1 Shares traded on the AIM, Aquis Stock Exchange (AQSE) and the
Main Market of the London Stock Exchange.
2
These holdings represent the treasury management
portfolio, which has been constructed from a range of carefully
selected, permitted non-qualifying holdings in investment trusts,
open-ended investment companies (OEICs) and money market funds
(MMFs).
Investment
Portfolio Summary
As at 31 August
2024
Investment
|
Valuation £'000
|
Cost £'000
|
% of total assets
|
% of equity held
|
% of equity held by other
clients1
|
Unlisted
|
|
|
|
|
|
Novatus Global
Limited
|
4,684
|
1,000
|
7.1
|
6.2
|
12.5
|
Bright Network (UK)
Limited
|
2,335
|
1,164
|
3.5
|
6.9
|
32.2
|
Rockar 2016 Limited
(trading as Rockar)
|
1,608
|
948
|
2.4
|
4.2
|
15.3
|
Horizon Ceremonies
Limited (trading as Horizon Cremation)
|
1,535
|
788
|
2.2
|
4.2
|
48.5
|
HCS Control Systems
Group Limited
|
1,246
|
846
|
1.9
|
6.9
|
29.6
|
DiffusionData
Limited
|
1,205
|
875
|
1.9
|
4.2
|
13.9
|
Zinc Digital Business
Solutions Limited
|
1,201
|
801
|
1.8
|
8.0
|
35.6
|
Summize
Limited
|
1,194
|
796
|
1.8
|
3.9
|
32.1
|
NorthRow
Limited
|
1,179
|
1,179
|
1.8
|
6.6
|
26.2
|
CB Technology Group
Limited
|
1,088
|
579
|
1.7
|
11.2
|
63.8
|
Martel Instruments
Holdings Limited
|
1,058
|
807
|
1.6
|
14.9
|
29.3
|
Bud Systems
Limited
|
1,057
|
846
|
1.6
|
4.7
|
13.0
|
Precursive
Limited
|
1,000
|
1,000
|
1.5
|
6.8
|
27.7
|
CYSIAM
Limited
|
986
|
373
|
1.5
|
6.0
|
21.7
|
2degrees Limited
(trading as Manufacture 2030)
|
970
|
698
|
1.5
|
2.5
|
8.6
|
Hublsoft Group
Limited
|
969
|
786
|
1.5
|
5.5
|
18.3
|
Nano Interactive
Group Limited
|
929
|
625
|
1.4
|
3.7
|
11.2
|
Enpal Limited
(trading as Guru Systems)
|
888
|
888
|
1.4
|
7.5
|
14.1
|
mypura.com Group
Limited (trading as Pura)
|
862
|
448
|
1.3
|
2.1
|
20.8
|
Vodat Communications
Group (VCG) Holding Limited
|
852
|
567
|
1.3
|
5.0
|
26.9
|
Horizon Technologies
Consultants Limited
|
828
|
796
|
1.3
|
5.5
|
11.7
|
QikServe
Limited
|
803
|
659
|
1.2
|
3.0
|
12.8
|
BioAscent Discovery
Limited
|
785
|
174
|
1.2
|
4.4
|
35.6
|
Ensco 969 Limited
(trading as DPP)
|
780
|
557
|
1.2
|
4.9
|
29.6
|
Liftango Group
Limited
|
763
|
763
|
1.2
|
4.7
|
36.0
|
Filtered Technologies
Limited
|
735
|
700
|
1.1
|
4.1
|
21.3
|
WaterBear Education
Limited
|
728
|
245
|
1.1
|
5.0
|
33.8
|
MirrorWeb Holdings
LLC2
|
708
|
708
|
1.1
|
1.1
|
3.9
|
Relative Insight
Limited
|
700
|
700
|
1.1
|
2.7
|
28.6
|
Sensoteq
Limited
|
697
|
697
|
1.1
|
6.6
|
17.0
|
Metrion Biosciences
Limited
|
696
|
696
|
1.1
|
5.1
|
13.1
|
XR Games
Limited
|
687
|
497
|
1.1
|
2.6
|
23.4
|
CODILINK UK Limited
(trading as Coniq)
|
675
|
450
|
1.0
|
1.3
|
3.6
|
Plyable
Limited
|
647
|
647
|
1.0
|
6.8
|
21.5
|
Reed Thermoformed
Packaging Limited (trading as iPac Packaging
Innovations)
|
631
|
448
|
1.0
|
2.5
|
9.9
|
Laverock Therapeutics
Limited
|
597
|
597
|
0.9
|
2.8
|
6.5
|
Biorelate
Limited
|
562
|
468
|
0.9
|
2.7
|
23.1
|
Cat Tech
International Limited
|
510
|
627
|
0.8
|
6.0
|
24.0
|
ORCHA Health
Limited
|
497
|
497
|
0.8
|
1.1
|
6.7
|
Draper & Dash
Limited (trading as RwHealth)
|
478
|
478
|
0.7
|
4.7
|
44.2
|
Whiterock Group
Limited
|
470
|
470
|
0.7
|
8.1
|
29.8
|
Flow UK Holdings
Limited
|
420
|
598
|
0.6
|
7.3
|
27.7
|
Rico Developments
Limited (trading as Adimo)
|
380
|
760
|
0.6
|
3.4
|
6.5
|
ebb3
Limited
|
370
|
252
|
0.6
|
8.0
|
70.9
|
HiveHR
Limited
|
346
|
346
|
0.5
|
4.4
|
40.2
|
Boomerang Commerce
Inc (trading as CommerceIQ)3
|
338
|
451
|
0.5
|
0.1
|
0.4
|
Delio
Limited
|
325
|
882
|
0.5
|
2.8
|
12.4
|
Automated Analytics
Limited
|
319
|
249
|
0.5
|
2.4
|
23.7
|
Snappy Shopper
Limited
|
309
|
309
|
0.5
|
0.4
|
1.3
|
Growth Capital
Ventures Limited
|
300
|
288
|
0.5
|
5.3
|
42.1
|
AMufacture
Limited
|
261
|
261
|
0.4
|
4.8
|
15.2
|
Alderley Lighthouse
Labs Limited
|
249
|
249
|
0.4
|
6.7
|
46.9
|
iAM Compliant
Limited
|
246
|
149
|
0.4
|
1.9
|
47.2
|
Shortbite Limited
(trading as Fixtuur)
|
239
|
884
|
0.4
|
6.9
|
50.5
|
The Algorithm People
Limited (trading as Optimize)
|
187
|
140
|
0.3
|
2.0
|
14.2
|
Zing TopCo
Limited
|
185
|
185
|
0.3
|
4.9
|
42.8
|
TC Communications
Holdings Limited
|
181
|
413
|
0.3
|
4.1
|
31.2
|
McKenzie Intelligence
Services Limited
|
159
|
159
|
0.2
|
1.6
|
4.8
|
RevLifter
Limited
|
100
|
100
|
0.2
|
1.0
|
25.6
|
ISN Solutions Group
Limited
|
84
|
323
|
0.1
|
4.6
|
50.4
|
Other unlisted
investments
|
11
|
2,750
|
-
|
|
|
Total unlisted
|
45,832
|
37,636
|
70.1
|
|
|
|
|
|
|
|
|
AIM/AQSE
quoted4
|
|
|
|
|
|
GENinCode PLC
|
319
|
557
|
0.6
|
2.8
|
10.6
|
Kanabo Group PLC5
|
155
|
1,639
|
0.3
|
2.0
|
7.9
|
Intelligent Ultrasound Group PLC
|
126
|
118
|
0.2
|
0.4
|
1.5
|
Incanthera PLC
|
108
|
46
|
0.2
|
0.5
|
0.5
|
Cambridge Cognition Holdings PLC
|
68
|
62
|
0.1
|
0.4
|
1.1
|
Arecor Therapeutics PLC
|
61
|
167
|
0.1
|
0.2
|
0.2
|
Eden Research PLC
|
39
|
59
|
0.1
|
0.2
|
1.3
|
Vianet Group PLC
|
38
|
37
|
0.1
|
0.1
|
1.3
|
Avacta Group PLC
|
31
|
7
|
-
|
-
|
-
|
C4X Discovery Holdings PLC
|
28
|
40
|
-
|
0.1
|
0.8
|
Feedback PLC
|
28
|
74
|
-
|
0.4
|
1.3
|
Crossword Cybersecurity PLC
|
20
|
150
|
-
|
0.5
|
1.3
|
Gelion PLC
|
19
|
121
|
-
|
0.1
|
0.1
|
Directa Plus PLC
|
14
|
120
|
-
|
0.1
|
0.1
|
Verici Dx PLC
|
12
|
63
|
-
|
0.1
|
0.8
|
XP Factory PLC
|
11
|
26
|
-
|
-
|
0.1
|
Angle PLC
|
10
|
50
|
-
|
-
|
-
|
Other AIM/AQSE investments
|
43
|
832
|
-
|
|
|
Total AIM/AQSE
quoted
|
1,130
|
4,168
|
1.7
|
|
|
|
|
|
|
|
|
Private equity investment
trusts6
|
|
|
|
|
|
HgCapital Trust
PLC
|
687
|
434
|
1.1
|
-
|
0.1
|
Patria Private Equity
Trust PLC (formerly abrdn Private Equity Opportunities Trust
PLC)
|
494
|
349
|
0.8
|
0.1
|
0.2
|
NB Private Equity
Partners Limited
|
417
|
430
|
0.6
|
0.1
|
0.2
|
ICG Enterprise Trust
PLC
|
406
|
343
|
0.6
|
0.1
|
0.2
|
Pantheon
International PLC
|
352
|
307
|
0.5
|
-
|
-
|
CT Private Equity
Trust PLC
|
334
|
276
|
0.5
|
0.1
|
0.3
|
HarbourVest Global
Private Equity Limited
|
334
|
194
|
0.5
|
-
|
-
|
Partners Group
Private Equity Limited
|
126
|
110
|
0.2
|
-
|
0.1
|
Apax Global Alpha
Limited
|
115
|
121
|
0.2
|
-
|
0.1
|
Caledonia Investments
PLC
|
101
|
100
|
0.2
|
-
|
-
|
Total private equity investment
trusts
|
3,366
|
2,664
|
5.2
|
|
|
|
|
|
|
|
|
Global equity investment
trusts6
|
|
|
|
|
|
Alliance Trust
PLC
|
288
|
280
|
0.4
|
-
|
-
|
Total global equity investment
trusts
|
288
|
280
|
0.4
|
|
|
|
|
|
|
|
|
Real estate investment
trusts6
|
|
|
|
|
|
Impact Healthcare
REIT PLC
|
103
|
114
|
0.2
|
-
|
0.2
|
Total real estate investment
trusts
|
103
|
114
|
0.2
|
|
|
|
|
|
|
|
|
Infrastructure investment
trusts6
|
|
|
|
|
|
3i Infrastructure
PLC
|
258
|
249
|
0.4
|
-
|
-
|
Pantheon
Infrastructure PLC
|
255
|
270
|
0.4
|
0.1
|
0.2
|
BBGI Global
Infrastructure SA
|
207
|
220
|
0.2
|
-
|
0.1
|
International Public
Partnerships Limited
|
124
|
140
|
0.2
|
-
|
-
|
JLEN Environmental
Assets Group Limited
|
117
|
150
|
0.2
|
-
|
0.1
|
Total infrastructure investment
trusts
|
961
|
1,029
|
1.4
|
|
|
|
|
|
|
|
|
Open-ended investment
companies6
|
|
|
|
|
|
Royal London Short
Term Money Market Fund (Class Y Income)
|
1,017
|
1,009
|
1.6
|
-
|
-
|
Royal London Short
Term Fixed Income Fund (Class Y Income)
|
1,010
|
1,018
|
1.5
|
0.1
|
-
|
Total open-ended investment
companies
|
2,027
|
2,027
|
3.1
|
|
|
|
|
|
|
|
|
Money market funds6
|
|
|
|
|
|
Aberdeen Standard
Liquidity Fund (Lux) - Sterling Fund (Class K3)
|
1,000
|
1,000
|
1.5
|
-
|
-
|
Aviva Investors
Sterling Government Liquidity Fund
|
1,000
|
1,000
|
1.5
|
-
|
-
|
Aviva Investors
Sterling Liquidity Fund (Class 3)
|
1,000
|
1,000
|
1.5
|
-
|
-
|
BlackRock
Institutional Sterling Liquidity Fund (Core)
|
1,000
|
1,000
|
1.5
|
-
|
-
|
HSBC Sterling
Liquidity Fund (Class A)
|
1,000
|
1,000
|
1.5
|
-
|
-
|
Fidelity
Institutional Liquidity Sterling Fund (Class F)
|
500
|
500
|
0.9
|
-
|
0.2
|
Total money market
funds
|
5,500
|
5,500
|
8.4
|
|
|
|
|
|
|
|
|
Total investments
|
59,207
|
53,418
|
90.5
|
|
|
1 Other clients of Maven Capital Partners UK LLP.
2 This holding reflects the retained minority interest following
the sale of MirrorWeb Limited to MirrorWeb Holdings LLC.
3 This holding reflects the retained minority interest following
the sale of e.fundamentals (Group) Limited to CommerceIQ in July
2022.
4 Investments are quoted on AIM/AQSE with the exception of
Kanabo Group PLC, which is listed on the Main Market of the London
Stock Exchange.
5 The holding in this investment resulted from the sale of The
GP Service (UK) Limited, which completed in February 2022. The
unlisted shares in Kanabo GP Limited were, in accordance with the
terms of the original transaction, exchanged for shares in Kanabo
Group PLC, which is listed on the Main Market of the London Stock
Exchange.
6 Treasury management portfolio.
Shaded line indicates that the investment was
completed pre November 2015.
Income
Statement
For the six
months ended 31 August 2024
|
Six months ended
31 August 2024
(unaudited)
|
Six months ended
31 August 2023
(unaudited)
|
Year ended
29 February 2024
(audited)
|
Revenue
£'000
|
Capital
£'000
|
Total
£'000
|
Revenue
£'000
|
Capital
£'000
|
Total
£'000
|
Revenue
£'000
|
Capital
£'000
|
Total
£'000
|
Gains/(losses) on
investments
|
-
|
4,064
|
4,064
|
-
|
(1,220)
|
(1,220)
|
-
|
(1,483)
|
(1,483)
|
Income from investments
|
536
|
-
|
536
|
380
|
-
|
380
|
858
|
-
|
858
|
Other income
|
90
|
-
|
90
|
106
|
-
|
106
|
183
|
-
|
183
|
Investment management
fees
|
(126)
|
(504)
|
(630)
|
(120)
|
(482)
|
(602)
|
(240)
|
(962)
|
(1,202)
|
Other expenses
|
(200)
|
-
|
(200)
|
(261)
|
-
|
(261)
|
(488)
|
-
|
(488)
|
Net return on ordinary activities before
taxation
|
300
|
3,560
|
3,860
|
105
|
(1,702)
|
(1,597)
|
313
|
(2,445)
|
(2,132)
|
Tax on ordinary
activities
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Return attributable to
Equity Shareholders
|
300
|
3,560
|
3,860
|
105
|
(1,702)
|
(1,597)
|
313
|
(2,445)
|
(2,132)
|
Earnings per share (pence)
|
0.19
|
2.22
|
2.41
|
0.07
|
(1.16)
|
(1.09)
|
0.21
|
(1.65)
|
(1.44)
|
All gains and losses are recognised in the
Income Statement.
The total column of this statement is the Profit
& Loss Account of the Company. The revenue and capital return
columns are prepared in accordance with the AIC SORP. All items in
the above statement derive from continuing operations. No
operations were acquired or discontinued during the
period.
There are no potentially dilutive capital
instruments in issue and, therefore, no diluted earnings per share
figures are relevant. The basic and diluted earnings per share are,
therefore, identical.
The accompanying Notes are an integral part of
the Financial Statements.
Statement of
Changes in Equity
For the Six
Months Ended 31 August 2024
Six months ended
31 August 2024
(unaudited)
|
Non-distributable reserves
|
Distributable reserves
|
Total
£'000
|
Share capital
£'000
|
Share premium account
£'000
|
Capital redemption reserve
£'000
|
Capital reserve unrealised
£'000
|
Capital reserve realised
£'000
|
Special distributable reserve
£'000
|
Revenue reserve
£'000
|
At 29 February 2024
|
15,469
|
23,119
|
835
|
5,676
|
(546)
|
15,598
|
872
|
61,023
|
Net return
|
-
|
-
|
-
|
2,046
|
2,018
|
(504)
|
300
|
3,860
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
(1,612)
|
(242)
|
(1,854)
|
Repurchase and cancellation
of shares
|
(381)
|
-
|
381
|
-
|
-
|
(1,425)
|
-
|
(1,425)
|
Net proceeds of share
issue
|
938
|
2,699
|
-
|
-
|
-
|
-
|
-
|
3,637
|
Net proceeds of DIS
issue*
|
43
|
122
|
-
|
-
|
-
|
-
|
-
|
165
|
At 31 August 2024
|
16,069
|
25,940
|
1,216
|
7,722
|
1,472
|
12,057
|
930
|
65,406
|
Six months ended
31 August 2023
(unaudited)
|
Non-distributable reserves
|
Distributable reserves
|
Total
£'000
|
Share capital
£'000
|
Share premium account
£'000
|
Capital redemption reserve
£'000
|
Capital reserve realised
£'000
|
Capital reserve realised
£'000
|
Special distributable reserve
£'000
|
Revenue reserve
£'000
|
At 28 February 2023
|
13,400
|
15,714
|
569
|
6,767
|
(154)
|
20,785
|
559
|
57,640
|
Net return
|
-
|
-
|
-
|
(1,211)
|
(9)
|
(482)
|
105
|
(1,597)
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
(1,713)
|
-
|
(1,713)
|
Repurchase and cancellation
of shares
|
(98)
|
-
|
98
|
-
|
-
|
(389)
|
-
|
(389)
|
Net proceeds of share
issue
|
1,513
|
5,092
|
-
|
-
|
-
|
-
|
-
|
6,605
|
Net proceeds of DIS
issue*
|
39
|
123
|
-
|
-
|
-
|
-
|
-
|
162
|
At 31 August 2023
|
14,854
|
20,929
|
667
|
5,556
|
(163)
|
18,201
|
664
|
60,708
|
Year ended
29 February 2024
(audited)
|
Non-distributable reserves
|
Distributable reserves
|
Total
£'000
|
Share capital
£'000
|
Share premium account
£'000
|
Capital redemption reserve
£'000
|
Capital reserve realised
£'000
|
Capital reserve realised
£'000
|
Special distributable reserve
£'000
|
Revenue reserve
£'000
|
At 28 February 2023
|
13,400
|
15,714
|
569
|
6,767
|
(154)
|
20,785
|
559
|
57,640
|
Net return
|
-
|
-
|
-
|
(1,091)
|
(392)
|
(962)
|
313
|
(2,132)
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
(3,191)
|
-
|
(3,191)
|
Repurchase and cancellation
of shares
|
(266)
|
-
|
266
|
-
|
-
|
(1,034)
|
-
|
(1,034)
|
Net proceeds of share
issue
|
2,261
|
7,179
|
-
|
-
|
-
|
-
|
*
|
9,440
|
Net proceeds of DIS
issue*
|
74
|
226
|
-
|
-
|
-
|
-
|
-
|
300
|
At 29 February 2024
|
15,469
|
23,119
|
835
|
5,676
|
(546)
|
15,598
|
872
|
61,023
|
*DIS represents the Dividend Investment Scheme
as detailed in the Interim
Review.
The capital reserve unrealised is generally
non-distributable, other than the part of the reserve relating to
gains/(losses) attributable to readily realisable quoted
investments that are distributable.
Where all, or an element of the proceeds of
sales have not been received in cash or cash equivalent, and are
not readily convertible to cash, they do not qualify as realised
gains for the purposes of distributable reserves calculations and,
therefore, do not form part of distributable reserves.
The accompanying Notes are an integral part of
the Financial Statements.
Balance
Sheet
As at 31 August
2024
|
31 August 2024 (unaudited)
£'000
|
31 August 2023 (unaudited)
£'000
|
29 February 2024
(audited)
£'000
|
Fixed assets
|
|
|
|
Investments at fair value
through profit or loss
|
59,207
|
53,514
|
55,384
|
Current assets
|
|
|
|
Debtors
|
607
|
658
|
460
|
Cash
|
5,935
|
6,849
|
5,476
|
|
6,542
|
7,507
|
5,936
|
Creditors
|
|
|
|
Amounts falling due within
one year
|
(343)
|
(313)
|
(297)
|
Net current assets
|
6,199
|
7,194
|
5,639
|
Net assets
|
65,406
|
60,708
|
61,023
|
Capital and reserves
|
|
|
|
Called up share capital
|
16,069
|
14,854
|
15,469
|
Share premium account
|
25,940
|
20,929
|
23,119
|
Capital redemption
reserve
|
1,216
|
667
|
835
|
Capital reserve -
unrealised
|
7,722
|
5,556
|
5,676
|
Capital reserve -
realised
|
1,472
|
(163)
|
(546)
|
Special distributable
reserve
|
12,057
|
18,201
|
15,598
|
Revenue reserve
|
930
|
664
|
872
|
Net assets attributable to Ordinary
Shareholders
|
65,406
|
60,708
|
61,023
|
Net asset value per Ordinary Share
(pence)
|
40.71
|
40.87
|
39.4
|
The Financial Statements of Maven Income and
Growth VCT PLC, registered number 03908220, were approved and
authorised for issue by the Board of Directors and were signed on
its behalf by:
John
Pocock
Director
24 October
2024
The accompanying Notes are an integral part of
the Financial Statements.
Cash Flow
Statement
For the Six
Months Ended 31 August 2024
|
Six months ended 31 August 2024
(unaudited)
£'000
|
Six months ended 31 August 2023
(unaudited)
£'000
|
Year ended
29 February 2024
(audited)
£'000
|
Net cash flows from operating
activities
|
(280)
|
(339)
|
(706)
|
Cash flows from investing
activities
|
|
|
|
Purchase of investments
|
(7,686)
|
(10,213)
|
(15,966)
|
Sale of investments
|
7,845
|
2,902
|
6,674
|
Net cash flows from investing
activities
|
159
|
(7,311)
|
(9,292)
|
Cash flows from financing
activities
|
|
|
|
Equity dividends paid
|
(1,854)
|
(1,713)
|
(3,191)
|
Issue of Ordinary
Shares
|
3,694
|
6,605
|
9,565
|
Net proceeds of DIS
issue
|
165
|
162
|
300
|
Repurchase of Ordinary
Shares
|
(1,425)
|
(389)
|
(1,034)
|
Net cash flows from financing
activities
|
580
|
4,665
|
5,640
|
|
|
|
|
Net increase/(decrease) in cash
|
459
|
(2,985)
|
(4,358)
|
Cash at beginning of period
|
5,476
|
9,834
|
9,834
|
Cash at end of period
|
5,935
|
6,849
|
5,476
|
The accompanying Notes are an integral part of
the Financial Statements.
Notes to the
Financial Statements
1.
Accounting
Policies
The financial information for the six months
ended 31 August 2024 and the six months ended 31 August 2023
comprises non-statutory accounts within the meaning of S435 of the
Companies Act 2006.The financial information contained in this
report has been prepared on the basis of the accounting policies
set out in the Annual Report and Financial Statements for the year
ended 29 February 2024, which have been filed at Companies House
and contained an Auditor's Report that was not qualified and did
not contain a statement under S498(2) or S498(3) of the Companies
Act 2006.
2.
Reserves
Share premium
account
The share premium account represents the premium
above nominal value received by the Company on issuing shares net
of issue costs, including £63,644 current period trail commission
(cumulative £189,110). This reserve is
non-distributable.
Capital
redemption reserve
The nominal value of shares repurchased and
cancelled is represented in the capital redemption reserve. This
reserve is non-distributable.
Capital reserve
- unrealised
Increases and decreases in the fair value of
investments are recognised in the Income Statement and are then
transferred to the capital reserve unrealised account. This reserve
is generally non-distributable other than the part of the reserve
relating to gains/(losses) attributable to readily realisable
quoted investments that are distributable.
Capital reserve
- realised
Gains or losses on investments realised in the
year that have been recognised in the Income Statement are
transferred to the capital reserve realised account on disposal.
Furthermore, any prior unrealised gains or losses on such
investments are transferred from the capital reserve unrealised
account to the capital reserve realised account on disposal. This
reserve is distributable.
Special
distributable reserve
The total cost to the Company of the repurchase
and cancellation of shares is represented in the special
distributable reserve account. The special distributable reserve
also represents capital dividends, capital investment management
fees and the tax effect of capital items. This reserve is
distributable.
Revenue
reserve
The revenue reserve represents accumulated
profits retained by the Company that have not been distributed to
Shareholders as a dividend. This reserve is
distributable.
3.
Return per Ordinary
Share
|
Six months ended
31 August 2024
|
The returns per share
have been based on the following figures:
Weighted average number of Ordinary Shares
Revenue return
Capital return
|
160,330,858
£300,000
£3,560,000
|
Total
return
|
£3,860,000
|
Directors'
Responsibility Statement
The Directors confirm that, to the best of their
knowledge:
• the Financial Statements for the
six months ended 31 August 2024 have been prepared in accordance
with FRS 102, the Financial Reporting Standard applicable in the UK
and Republic of Ireland;
• the Interim Management Report
includes a fair review of the information required by DTR 4.2.7R in
relation to the indication of important events during the first six
months, and of the principal risks and uncertainties facing the
Company during the second six months, of the year ending 28
February 2025; and
• the Interim Management Report
includes adequate disclosure of the information required by DTR
4.2.8R in relation to related party transactions and any changes
therein.
Other
information
The NAV per Ordinary Share at 31 August 2024 has
been calculated using the number of Ordinary Shares in issue of
160,679,275.
A full copy of the Interim Report and Financial
Statements will be issued to Shareholders. Copies of this
announcement will be available to the public at the office of Maven
Capital Partners UK LLP, Kintyre House, 205 West George Street,
Glasgow G2 2LW and at the registered office of the Company, 6th
Floor, Saddlers House, 44 Gutter Lane, London EC2V 6BR.
Neither the content of the Company's webpage nor
the contents of any website accessible from hyperlinks on the
Company's webpage (or any other website) is incorporated into, or
forms part of, this announcement.
By order of the
Board
Maven Capital
Partners UK LLP
Secretary
24 October
2024